HDAC Inhibitors As Novel Targeted Therapies for NUP98-HOXA9 AML Patients

被引：1
|
作者：
Rio-Machin, Ana [1 ,2 ]
Gomez-Lopez, Gonzalo [3 ]
Maiques-Diaz, Alba [2 ]
Alvarez, Sara [2 ]
Calasanz, Maria Jose [4 ]
Fitzgibbon, Jude [1 ]
Cigudosa, Juan C. [2 ]
机构：
[1] Queen Mary Univ London, Barts Canc Inst, Ctr Haematooncol, London, England
[2] Ctr Nacl Invest Oncol, Mol Cytogenet Grp, Human Canc Genet Programme, Madrid, Spain
[3] Ctr Nacl Invest Oncol, Bioinformat Unit, Madrid, Spain
[4] Univ Navarra, Sch Med, Dept Genet, IDISNA, Pamplona, Spain
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.2685.2685
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2685
引用
收藏
页数：4
相关论文
共 50 条
  • [21] THE FUSION GENE NUP98-HOXA9 AS A MODEL FOR LEUKEMOGENESIS: EXPLORING ITS MOLECULAR MECHANISMS AND FUNCTIONAL EFFECTS
    Rio-Machin, A.
    Rodriguez-Perales, S.
    Ramirez, J.
    Torres, R.
    Alvarez, S.
    Cigudosa, J.
    HAEMATOLOGICA, 2013, 98 : 13 - 14
  • [22] NUP98-HOXA9 expression in hemopoietic stem cells induces chronic and acute myeloid leukemias in mice
    Kroon, E
    Thorsteinsdottir, U
    Mayotte, N
    Nakamura, T
    Sauvageau, G
    EMBO JOURNAL, 2001, 20 (03): : 350 - 361
  • [23] Smad4 inhibits Nup98-Hoxa9 transcriptional activity by interacting at Hox homeodomain.
    Wang, N
    Wan, M
    Tang, Y
    Kim, HG
    Cotta, C
    Klug, CA
    Cao, X
    BLOOD, 2004, 104 (11) : 704A - 704A
  • [24] Over-expression of the human AML-associated fusion gene NUP98-HOXA9, in murine bone marrow cells leads to myelo-proliferation and AML.
    Kroon, E
    Thorsteinsdottir, U
    Nakamura, T
    Sauvageau, G
    BLOOD, 1999, 94 (10) : 694A - 694A
  • [25] Enforced expression of NUP98-HOXA9 in human CD34+ cells enhances stem cell proliferation
    Chung, Ki Y.
    Morrone, Giovanni
    Schuringa, Jan Jacob
    Plasilova, Magdalena
    Shieh, Jae-Hung
    Zhang, Yue
    Zhou, Pengbo
    Moore, Malcolm A. S.
    CANCER RESEARCH, 2006, 66 (24) : 11781 - 11791
  • [26] Epigenetic and functional changes imposed by NUP98-HOXA9 in a genetically engineered model of chronic myeloid leukemia progression
    Sloma, Ivan
    Beer, Philip
    Desterke, Christophe
    Bulaeva, Elizabeth
    Bilenky, Misha
    Carles, Annaick
    Moksa, Michelle
    Raghuram, Kamini
    Brimacombe, Cedric
    Lambie, Karen
    Turhan, Ali G.
    Wagner-Ballon, Orianne
    Gaulard, Philippe
    Humphries, Keith
    Hirst, Martin
    Eaves, Connie J.
    HAEMATOLOGICA, 2021, 106 (03) : 881 - 885
  • [27] BCR-ABL interacts with NUP98-HOXA9 and with E2a-PBX1 in human leukemias.
    Sauvageau, G
    Hendrix, A
    Denis, DC
    Kroon, E
    Hébert, J
    Mayotte, N
    BLOOD, 2001, 98 (11) : 837A - 837A
  • [28] Oncogenic interaction between BCR-ABL and NUP98-HOXA9 demonstrated by the use of an in vitro purging culture system
    Mayotte, N
    Roy, DC
    Yao, J
    Kroon, E
    Sauvageau, G
    BLOOD, 2002, 100 (12) : 4177 - 4184
  • [29] NUP98-HOXA9 Reprograms Embryonic Hematopoiesis, Suppresses Cellular Apoptosis, and Causes Malignant Tissue Infiltrates in Transgenic Zebrafish
    Forrester, A. Michael
    Boyd, Ellen R.
    Grabher, Clemens
    McBride, Eileen R.
    Da'as, Sahar
    Kai, Fui Boon
    Look, A. Thomas
    Berman, Jason N.
    BLOOD, 2009, 114 (22) : 1523 - 1523
  • [30] Amino-terminal Enhancer of Split (AES) Interacts with the Oncoprotein NUP98-HOXA9 and Enhances Its Transforming Ability
    Sarma, Nayan J.
    Yaseen, Nabeel R.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (45) : 38989 - 39001
12345